Zhong Guo Zhi Liang Xin Wen Wang·2025-08-07 08:42Group 1 - Guangdong Haida Group Co., Ltd. is acquiring equity in Zhuhai Dehai Biotechnology Co., Ltd., with the case expected to be concluded by July 30, 2025 [1] - China International Pharmaceutical Health Co., Ltd. and China National Pharmaceutical International Hong Kong Co., Ltd. are acquiring Shandong Luzhong Investment Co., Ltd., with the case expected to be concluded by July 30, 2025 [2] - Shanghai Zhiheng New Energy Co., Ltd. is establishing a joint venture with China Resources Power Holdings Co., Ltd., with the case expected to be concluded by August 1, 2025 [3] Group 2 - Anhui Conch Cement Co., Ltd. is acquiring assets from multiple companies including Yili Yaobai Cement Co., Ltd. and Xinjiang Baihang Environmental Technology Co., Ltd., with the case expected to be concluded by August 1, 2025 [4] - Yangzhou Lianhuan Investment Co., Ltd. is acquiring equity in Sichuan Longyi Pharmaceutical Co., Ltd., with the case expected to be concluded by August 1, 2025 [5] - Ampere Investment Company is establishing a joint venture with China International Capital Corporation Private Equity Investment Management Co., Ltd., with the case expected to be concluded by August 1, 2025 [6]